Hypercholesterolemia Clinical Trial
Official title:
Endurance Training and Post-exercise Low Glycemic Index Recovery Diet for Improving Postprandial Triglycerides
Postprandial triglycerides are a strong risk factor for heart disease. The purpose is to assess the effects of a low-glycemic versus high-glycemic meal after 90 minute exercise sessions that are done 4 times a week for 6 weeks on postprandial triglyceride level. Secondary measurements include other lipids and body composition.
The increase in triglycerides after a meal (i.e. postprandial triglycerides) is a strong risk
factor for cardiovascular disease. Overweight/obese individuals have a greater triglyceride
response to the same meal compared to lean individuals; therefore they are at greater risk.
If exercise is performed the evening before a high-fat breakfast, the postprandial levels of
triglycerides after the breakfast are reduced; however, if high glycemic index (GI) foods are
consumed after the exercise session, the benefits of exercise on next-day postprandial
triglycerides is negated. The investigators recently showed (HSFC funded) that consuming low
GI foods after exercise is similar to fasting after exercise and superior to consumption of
high GI foods for lowering next-day postprandial triglycerides. Low GI food was also superior
for increasing fat oxidation, and lowering insulin, and low and very low density lipoproteins
and preventing a decrease in high density lipoproteins. The benefits of an acute exercise
session followed by low GI food consumption is now clear; however, it is not known whether
this practice over weeks of exercise training results in accumulated and sustained benefits.
The purpose of this study is to determine the chronic effects of consuming low compared to
high GI foods after exercise sessions over six weeks in overweight and obese individuals.
Twenty-four overweight and obese males and females will be randomized to consume either high
or low GI foods immediately after exercise sessions (four sessions per week, 90 minutes per
session, six weeks). At all other times of the day over the six weeks, they will be supplied
a moderate GI diet, with calories and macronutrients based on four-day food diaries completed
before the study. Two weeks before the intervention, participants will be required to go on
the moderate GI diet, as a lead-in. One week into the lead-in, a baseline test will be done
to determine postprandial metabolic responses (i.e. triglycerides, low and very low density
lipoproteins, high density lipoproteins, insulin, and fat oxidation) after a morning high-fat
breakfast. A week later, the same postprandial testing will be carried out the morning after
the first exercise and post-exercise consumption of a low or high GI recovery meal.
Participants will continue the training and post-exercise food consumption for the next six
weeks, with postprandial measures taken again following the final exercise and feeding
session. Body composition and aerobic fitness will be determined before and after the six
week intervention.
The investigators hypothesize that the low GI post-exercise feeding will be superior to the
high GI post-exercise feeding for reducing body fat, improving fat oxidation, and reducing
postprandial triglycerides, insulin and other harmful lipids. The results of the study will
provide clinicians, exercise professionals and dietitians unique and experimentally tested
strategies for their clients to lose body fat and improve metabolic profiles, to reduce the
risk of heart disease.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Recruiting |
NCT03947866 -
Ezetimibe-Rosuvastatin Evaluation Study
|
||
Completed |
NCT01709513 -
Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)
|
Phase 3 | |
Completed |
NCT01212900 -
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
|
Phase 4 | |
Completed |
NCT00001154 -
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
|
||
Completed |
NCT02550288 -
A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
|
Phase 3 | |
Completed |
NCT03929198 -
Translation of Pritikin Program to the Community
|
N/A | |
Completed |
NCT04485793 -
Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia
|
N/A | |
Completed |
NCT02341924 -
Validating the "Foods for Health" Portfolio of Functional Food Products
|
N/A | |
Active, not recruiting |
NCT02223793 -
Vascular Lifestyle-Intervention and Screening in Pharmacy
|
N/A | |
Completed |
NCT01941836 -
Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients
|
Phase 2 | |
Completed |
NCT01934608 -
The Effect of Synching Prescription Refills on Adherence
|
N/A | |
Recruiting |
NCT01705873 -
Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
|
N/A | |
Completed |
NCT01670734 -
Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01678521 -
Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients
|
N/A | |
Completed |
NCT01370590 -
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
|
Phase 3 | |
Completed |
NCT01370603 -
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
|
Phase 3 | |
Completed |
NCT01478789 -
Efficacy of Plant Sterol-Fortified Dairy Product on Plasma Lipid and Plant Sterol Concentrations in Humans
|
N/A | |
Completed |
NCT01768403 -
Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia
|
N/A | |
Completed |
NCT01446679 -
Special Drug Use-Results Survey of Lipitor Tablets
|
N/A |